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ABSTRACT 
Most herbal products are used with prescription drugs and have been found to affect the pharmacokinetics of these prescription 
drugs. The effect of concurrent administration of Garcinia kola on the pharmacokinetic parameters and penetration profile of 
rifampicin into the lung tissues were investigated using animal model. Albino rats in group A received rifampicin 10 mg/kg alone 
orally; Group B and C received 100 mg/kg and 200 mg/kg of Garcinia kola extract respectively for 10 days and on day 11, rifampicin 
10 mg/kg was given. Blood samples were withdrawn from each group at 0.5, 1, 2, 4, 8, 12 and 24 h time intervals respectively. 
Blood samples were also withdrawn from the lungs in each group after 24 h and assayed to determine the concentration of rifampicin 
in the lungs. Both 100 and 200 mg/kg of Garcinia kola showed reduction in the maximum concentration (Cmax), area under 
concentration (AUC), clearance time (ClT), and time for plasma concentration to decrease by half (t1/2) of rifampicin. Garcinia kola 
significantly (P = 0.01) decreased concentration of rifampicin in the lungs by 32% and 39 % respectively. Our results show that the 
co-administration of Garcinia kola and rifampicin impairs the bioavailability of rifampicin and its penetration into the lungs.  
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Plants naturally produce large number of diverse bioactive 
compounds used for management of ailments (Altemimi et al., 
2017; Dranca and Oroian, 2016). Thus the use of herbs in 
disease management has historical and traditional background 
with a belief that they are safe (Mohammad and Mohammad, 
2009).  Traditional knowledge of the values of these plants were 
earlier downplayed by pressures of modern lifestyle, orthodox 
medicine and effects of rampant deforestation (Onyekwelu et 
al., 2015); However current researches has fanned into flame the 
indispensable use of plants in disease management. Recently, 
the rate of self-medication with herbs and food supplement is on 
the increase and this has led to greater potentials for interaction 
between these agents when administered concurrently with 
prescription drugs (Ulbricht et al., 2008). Though people believe 
that natural plants are safe, they contain active constituents in 
varying proportions which make them potential drugs as well as 
poisons. Of great concern is the fact that as herbal drugs and 
food supplement becomes more popular, the more the 
consumers, health professionals and manufacturers tend to 
overlook the issue of safety concerning them. It is on this ground 
that most of the commonly used herbs are under researched by 
researcher Clinical Pharmacokinetics is the use of principles 
derived from pharmacokinetics in the management of patient 
drug therapy. Basic parameters that influence these principles 
are Peak Plasma Concentration (Cmax) and the time it takes to 
reach this peak (Tmax). These two parameters are influenced by 
rate of absorption. Other factors include elimination half-life 
which is very useful in the calculation of drug dosage regimen; 
Volume of distribution which is simply a proportionality 
constant whose sole purpose is to relate the plasma 
concentration (Cp) and the mass of drug (X) in the body at a 
time. It is not a physiological volume”. [4].Volume of 
distribution is very vital in determining how readily an 
administered drug is distributed between the body tissues and 
blood; Clearance which is an inevitable parameter in the 
calculation of loading dose and dose needed to maintain steady 
state concentration 
 In Africa, Garcinia Kola (Clusiaceae), known as bitter kola 
is a treasured multipurpose tree indigenous to West and Central 
Africa. Garcinia Kola tree is often referred to as “wonder plant” 
because all of its part is medicinal (Manourová et al.,2019; 
Onasanwo et al., 2016). Its seed has been used in several ways 
in the management of a good number of health problems 
(Ezeigbo et al., 2016) which include liver disease, cold, cough 
aphrodisiac, voice coarseness (Farombi, 2011; Alabi et al., 
2017), and neurodegenerative diseases such multiple sclerosis 
(Omotoso et al., 2018).Other studies shows it has antibacterial 
activities  against multi-drug-resistant A. baumannii (Badger-
Emeka et al., 2018), anti-inflammatory and pain relieving 
effects (Ibironke et al., 2015; Tchimene et al., 2016) 
 Some of the phytochemicals compounds in G. kola include: 
oleoresin, tannin, saponin, alkaloids, cardiac glycoside, 
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flavonoids and metallic ions like aluminium, magnesium, 
calcium, copper. Its flavonoid extract - kolaviron possess anti-
malarial, wound healing properties (Nwaehujor, et al., 2015; 
Tshibangu,et al., 2016), is effective in treatment of benign 
prostatic hyperplasia (Kalu, et al., 2016) and can be clinically 
active against ischemia/reperfusion injuries (Akinmoladun et 
al.,2015) 
 Studies have shown that flavonoids and metallic ions form 
various intermolecular complexes with a variety of compounds 
(; Terashima et al., 2002, Esimone, 2002a). Earlier studies have 
shown that ethanol extract of Garcinia kola has activities against 
the antimicrobial properties of some commonly used antibiotics 
such as tetracycline, gentamycin, penicillin G, ofloxacin, co-
trimoxazole and amoxicillin-clavulanic acid, when administered 
concurrently (Esimone et al., 2007; Esimone et al., 2002a; 
Esimone et al., 2003).  
 Rifampin is a semisynthetic antibiotic produced from 
Streptomyces mediterranei. It has a broad antibacterial 
spectrum, including activity against several forms of 
Mycobacterium. In susceptible organisms it inhibits DNA-
dependent RNA polymerase activity by forming a stable 
complex with the enzyme. It thus suppresses the initiation of 
RNA synthesis. Rifampin is bactericidal, and acts on both 
intracellular and extracellular organisms. (William, 2001) 
Rifampicin is an antitubercular medicine which helps to treat 
tuberculosis and meningococcal meningitis. A common side 
effect of rifampicin includes reddish colouration of the urine, 
sweat, sputum and tears. WHO has recommended that 
tuberculosis (TB) should be treated with a combination of anti-
TB drugs, preferably in fixed dose combinations (FDC) to 
enhance compliance. Rifampicin is one of the first-line and most 
important anti-TB drugs approved for use in combination with 
other anti-TB drugs for the treatment of TB. Earlier researchers 
have shown that rifampicin exhibits variable bioavailability 
upon administration, being less soluble and highly permeable. 
(Ashokraj et al., 2008). Hence worldwide, the recommended 
administration of rifampicin is before breakfast. Therefore, 
challenges such as suboptimal or failed treatment resulting from 
interaction with another drug, food or herb could occur (Neralla 
and Glassroth, 2003).  
 The most valued part of the tree is the seed, which is 
commonly eaten to prevent or cure gastric disorders and for their 
typical astringent taste (Manourová et al., 2019). This is 
supported by the work of Oluwatosin et al., who reported that 
some people consume Garcinia kola seeds instead of cola nuts 
coming from Cola spp (Oluwatosin et al., 2014). There are no 
reports of harmful effects resulting from overdosing with G. 
kola, (Konziase, 2015) hence it is safe for consumption. 
Esimone et al., 2003 has shown that in Nigeria, most patients on 
antibiotics therapy also consume G. kola habitually or as a result 
of the general belief that it has anti-infective properties. 
Therefore, this study was designed to investigate the effect of 
co-administration of G. kola extracts on the pharmacokinetic 
parameters and penetration profile of rifampicin into the lung 
tissue. 
 
MATERIALS AND METHODS 
 
Drug and Plant Material: Rifampicin (Sanofi-aventis Ltd, 
Lagos Nigeria) and Garcinia kola were used. Garcinia kola 
seeds used in this study were obtained locally in Nsukka 
(Southeast Nigeria), authenticated at the Department of 
Pharmacognosy, University of Nigeria, Nsukka and stored in 
their herbarium. 
Animals: Albino rats (190-300g) of both sexes were obtained 
from the Faculty of Veterinary Medicine, University of Nigeria, 
Nsukka. The animals were monitored under light and dark cycle 
in metabolic well-ventilated rodent cubicle before 
commencement of the experiment for the purpose of 
acclimatization. Measures like separate housing by sex was 
taken to avoid conception. Food and water were allowed them 
within the period of monitoring but was withdrawn 12 h before 
the commencement of the experiment. The animals were 
handled according to internationally and locally approved 




Extraction of Garcinia kola: The seeds of G. kola were 
washed, peeled, dried and pulverized in a milling machine into 
powder (gumming form). About 2 kg powder of the G. kola was  
placed into 10 L maceration bottle with 5 L of ethanol and was 
macerated for 72 h, after maceration, the solvent was sieved out 
with porcelain cloth and later with 22 cm filter paper. The 
extract was evaporated to dryness using rotary evaporator. The 
sample was collected and stored in refrigerator at 4 °C. 
 
Beer-lambert’s Plot: The standard solutions of Rifampicin was 
prepared in the concentration of 1 to 8 μg/ml and dissolved in 3 
ml plasma. The plasma solutions were further diluted with 10 % 
v/v of methanol and determine the absorbance of the samples 
using UV spectrophotometer (Sp-6-450 UV/Vis Pye unicam). In 
the method, protein free samples were prepared by mixing each 
sample of 5ml plasma with equal volume of 10 %v/v of 
methanol; the samples were centrifuged and filtered (Onyishi et 
al., 2014). The absorbances of the filtrates collected were 
determined at 375nm using spectrophotometer. 
 
Administration of Garcinia kola/Rifampicin and 
determination of plasma drug concentrations in rats: Fifteen 
albino rats were divided into three groups: A, B and C. The 
experiment was carried out in 3 Phases. In Phase 1, Group A 
received 10 mg/kg of rifampicin alone orally. In Phases 2 and 3, 
Groups B and C received 100 mg/kg and 200 mg/kg of G. kola 
extract respectively for 10 days and on day 11, rifampicin 10 
mg/kg was given as in group A. Blood samples were collected 
from each group at 0.5, 1, 2, 4, 8, 12 and 24 h time intervals 
respectively (Onyishi et al., 2014) for the determination of 
plasma drug concentration in the rats. 
 
Determination of the effects of Garcinia kola on rifampicin 
penetration into the lungs: At the 24th h, following the oral 
administration of rifampicin and G. kola in each group, all the 
animals were sacrificed with chloroform and their lungs 
collected. Blood was also withdrawn from the lung area with 
their plasma collected after centrifugation. For the purpose of 
removing contaminated blood, non-bacteriostatic saline was 
used to rinse the lungs. Each lung was homogenized individually 
and centrifuged to collect fluid and stored in a refrigerator for 
preservation before assay.  
 
Determination of pharmacokinetic parameters: Following a 
single oral administration of rifampicin, different 
pharmacokinetic parameters were determined using non-
compartmental method as implemented in WinNonLin 
pharmacokinetic programs (version 5.0), (Pharsight 
Corporation, Mountain View California). Pharmacokinetic 
properties of rifampicin were determined for each animal.  
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Statistical Analysis 
In analyzing this result, it was assumed that after administration, 
rifampicin followed first order kinetics. Results were expressed 
as mean ± standard deviation (SD) and statistical comparisons 
for differences among the treatment groups were made using the 
students’ paired t-test and one way analysis of variance 
(ANOVA). Data were analyzed at 95 % confidence interval with 




Effect of Garcinia kola (100 mg/kg) on rifampicin (10 mg/kg) 
plasma concentration in rats following a single oral 
administration of rifampicin: When rifampicin was 
administered alone, it attained its maximum concentration of 
18.24 ± 1.38 μg/ml at 1 h, while co-administration with G. kola 
at 100 mg/kg achieved a maximum concentration of 16.58 ± 
1.07 μg/ml at the same 1 h. The difference in the concentration 
of rifampicin alone and that of rifampicin and 100 mg/kg G. kola 
was statistically significant (P = 0.03).  The concentrations 18.00 
± 0.80, 16.57 ± 0.45, 16.29 ± 0.42, 15.26 ± 0.33 and 11.30 ± 
1.29 μg/ml were obtained at 2, 4, 8, 12 and 24 h respectively for 
rifampicin alone while concentrations of 15.92 ± 0.90, 15.05 ± 
1.38, 13.92 ± 0.80, 9.57 ± 1.72 and 7.05.37 ± 1.29 μg/ml were 
obtained at 2, 4, 8, 12 and 24 h for rifampicin + 100 mg/kg G. 
kola. A graphical representation of rifampicin concentration 
(μg/ml) at different time intervals following oral administration 
of rifampicin alone (10 mg/kg) and in the presence of 100 mg/kg 
Garcinia kola is shown in Fig. 1.  
 
Effect of Garcinia kola (200mg/kg) on rifampicin (10 mg/kg) 
plasma concentration in rats following a single oral 
administration of rifampicin: Administration of rifampicin 
alone attained the maximum concentration of 18.24 ± 1.38 
μg/ml within 1 h, which was significantly difference (P = 0.02) 
compared to the maximum concentration of 16.28 ± 2.41 μg/ml 
obtained from rifampicin plus 200 mg/kg of G kola within the 
same 1 h. The concentrations of 18.00 ± 0.80, 16.57 ± 0.45, 
16.29 ± 0.42, 15.26 ± 0.33 and 11.30 ± 1.29 μg/ml were obtained 
at 2, 4, 8, 12 and 24 h respectively for rifampicin alone while 
concentrations of 15.00 ± 1.58, 14.84 ± 1.51, 12.03±0.86, 9.80 
± 1.51 and 7.25 ± 1.81 μg/ml were obtained at 2, 4, 8, 12 and 24 
h for rifampicin plus 200 mg/kg G. kola. A graphical 
representation of rifampicin concentration (μg/ml) at different 
time intervals following oral administration of rifampicin alone 
(10 mg/kg) and in the presence of 200 mg/kg Garcinia kola is 
shown in Figure 2. There was no statistical difference (P = 0.10) 
in the plasma concentration of rifampicin produced by 100 
mg/kg of Garcinia kola compared to that of 200 mg/kg.
 
    
 
 
Table 1:  
Pharmacokinetic parameters of rifampicin (10mg/kg) administered orally alone and Rifampicin+100 and 200 mg/kg of Garcinia kola in rats.  
(Mean ± SEM) (n = 5) 
PARAMETER RIF ALONE RIF +100mg/kg GK (% change in parenthesis) RIF + 200mg/kg GK (% change in parenthesis) 
Tmax (hr) 5.60 ± 4.60 5.4 ± 2.69 (3.57) 5.30 ± 1.09(5.36) 
Cmax (μg/ml) 18.60 ± 0.42 16.01 ± 0.52*(13.92) 15.08 ± 0.64(2.80)* 
Clast (μg/ml) 17.30 ± 0.51 14.52 ± 0.47* (16.07) 16.76 ± 0.74(3.12) 
AUC (μg/ml/hr) 377.35 ± 2.77 351.67 ± 4.38(6.80) 309.76 ± 28.4*(17.92) 
t½ (hr) 9.53 ± 2.80 1.26 ± 1.96*(86.78) 2.45 ± 1.21*(74.29) 
Vd (ml/kg) 0.63 ± 0.04 0.60 ± 0.003(4.76) 0.54 ± 0.07(14.28) 
CL (ml/kg/hr) 0.009 ± 0.02 0.007 ± 0.04(22.22) 0.002 ± 0.04*(77.78) 
AUMC (μg/ml/hr2) 4739.05 ± 71.56 4257.50 ± 50.55(10.16) 2420.70± 88.64*(48.92) 
MRT (hr) 12.57 ± 0.12 13.9 ± 0.138(-10.60) 15.8 ± 3.66(-25.69) 
SEM = standard error of mean; n = number of animal per group, * P < 0.05, The negative sign = decrease in parameter measured; RIF = 
Rifampicin; GK = Garcinia kola; Tmax =  time taken for drugs to attain maximal plasma concentration; Cmax = maximal drug plasma concentration; 
Clast = measurable drug plasma concentration; AUC = area under concentration time curve from the time of dosing to the time of the last 
observation; AUMC = area under moment curve from the time of dosing to the time of last measurable concentration; MRT = mean residence 
time t½ is terminal half-life; Vd = volume of distribution based on the terminal phase; CL = total body clearance.  
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Effects of 100 and 200 mg/kg Garcinia kola on 
Pharmacokinetics parameters of Rifampicin: The concurrent 
administration of both 100 and 200 mg/kg of G. kola showed a 
non-significant (P = 0.03) decrease in the Tmax from 5.60 ± 4.60 
to 5.4 ± 2.69 and 5.60 ± 4.60 to 5.30 ± 1.90 respectively. There 
was a significant (P = 0.02 decrease in the Cmax and from 18.60 
± 0.42 to 16.01 ± 0.52 for 100 mg/kg G. kola and 15.08 ± 0.64 
for 200 mg/kg G. kola. The t1/2 was also significantly (P = 0.001 
reduced from 9.35 ± 2.80 to 1.26 ± 1.96 for 100 mg/kg G. kola 
and to 2.45 ± 1.21 for 200 mg/kg G. kola.  There was no 
statistically significant difference (P = 0.20) in the 
pharmacokinetic parameters of rifampicin produced by 100 
mg/kg of Garcinia kola compared to that of 200 mg/kg. The 
effect of 100 and 200 mg/kg of Garcinia kola on other 
pharmacokinetic parameters of rifampicin are showed in Table 
1 
 
Effect of Garcinia kola on rifampicin penetration into the lung 
Analysis of the result showed that concentration of rifampicin 
alone in the lung cavity was 14.63 ± 4.06 while that obtained 
from rifampicin+100 and 200 mg/kg G. kola were 9.81 ± 0.45 
and 8.93 ± 0.5 respectively. The reduction in concentration was 
statistically significant at P = 0.01. A graphical representation of 
the effect of Garcinia kola on rifampicin penetration into the 
lung is shown in Figure 3.  
 
 
Figure 3:  
Effect of 100 and 200 mg/kg Garcinia kola extracts on the 




The significance of food-drug interaction as a variable in 
bioavailability of drugs is now recognized. A major goal of an 
interaction study is to determine whether there is any increase or 
decrease in pharmacokinetic properties of a drug in the presence 
of an interacting substrate, because this has a potential to 
influence therapeutic outcomes. Hence the results of this work 
show that there is potential interaction between rifampicin and 
Garcinia kola when administered concurrently.  
 Both doses of Garcinia kola reduced the plasma 
concentration of rifampicin, which resulted in a decrease in 
maximum concentration (Cmax) and AUC of rifampicin 
compared to the Cmax and AUC observed with rifampicin alone. 
The mechanism by which G. kola elicits this effect was not 
investigated, but could be attributed to some factors relating to 
its constituents. Flavonoids and metallic ions are known to form 
intermolecular complexes with a wide range of compounds. 
Previous works on phytochemical analysis of G. kola shows that 
it contains flavonoids (Terashima et al., 2002, Esimone, 2002a) 
and metallic ions like aluminum, magnesium, calcium, copper 
(Esimone et al., 2003). The complex formed is usually non-
absorbable which results in reduction in the amount of drug 
absorbed leading to reduced Cmax and AUC. Also, food intake 
has been reported to increase the absorption of some drugs like 
sulphadimidine and griseofulvin while decreasing the 
absorption of others like penicillins and cephalexins (Iwu and 
Igboko, 1986).  
 In this study the presence of G. kola decreased the absorption 
hence the concentration of rifampicin which is indicative of 
reduced systemic bioavailability of rifampicin due to actual 
herb-drug interaction. This decrease in rifampicin Cmax and AUC 
by G. kola is similar to the work by Igbinoba et al., who recorded 
decreased Cmax and AUC of quinine by G. kola (Igbinoba et al., 
2014).  In the management of any disease, decrease in Cmax of 
antibiotic leads to microorganism being exposed to sub-optimal 
concentrations with the possibility of drug resistance by the 
organism and consequent therapeutic failure.  
 There was a  decrease  in the time (Tmax) for achieving Cmax 
by rifampicin alone when compared to that of both the 100 and 
200 mg/kg G. kola, while there was a significant decrease (P = 
0.001)  in t1/2 in the treatment group compared to the group that 
took rifampicin alone. The decrease in Tmax and t1/2 suggests that 
G. kola affects both the rate and extent of rifampicin availability 
for absorption. This implies that the rifampicin dosage regimen 
needs to be adjusted downwards. Since t1/2 is a major 
determinant in the calculation of drug dosage regimen, any drug 
that affects it will also affect the dosing of such drug. 
 The clearance of rifampicin was reduced in the treatment 
group of 100 mg/kg G. kola the reduction became significant (P 
< 0.01 with 200 mg/kg G. kola. The significant decrease in total 
clearance (CL) suggests that G. kola may have induced 
decreased metabolism of rifampicin. It can be deduced that 
inhibition of liver metabolic enzymes played important role in 
the delayed elimination of rifampicin irrespective of the known 
potent liver enzyme induction by rifampicin. The treatment 
group also showed increase in the mean resident time (MRT) 
confirming delayed clearance. MRT is better appreciated when 
described as the residence time of individual molecules in the 
body. Each molecule of a drug spends a specific amount of time 
in the body, some lasting longer than the other, hence the need 
for calculation of the mean resident time molecules.  Increase in 
MRT suggests that in the presence of G. Kola, some of its 
molecules still stay longer in the body than when given alone.  
 Reduced efficacy of tuberculosis therapy (TB) has been 
shown to be due to but not limited to factors such as high 
bacterial load and presence of resistant strain resulting to poor 
therapeutic outcome (Mitchison and Coates, 2004; Sacchetini et 
al., 2008). Analysis of the concentration of rifampicin in the 
lung tissue to assess the effect of G. kola on its penetration into 
the lungs revealed that G. kola caused a significant (P = 0.01) 
reduction on the concentration of rifampicin in the lung tissue. 
The plasma concentration of rifampicin for both rifampicin 
alone and rifampicin plus G. kola was higher than the 
concentrations obtained from lung tissues. Our result is in 
agreement with few studies published earlier indicating that in 
some remote target sites drug concentration can be reduced and 
the degree of reduction differs from drug to drug. (Din et al., 
2017; Rizvi and Saleh, 2017).  
 The observed decrease in concentration of rifampicin in the 
lung tissue when taken concurrently with G. kola seed has 
various therapeutic implications and is of clinical importance 
especially in the management of Mycobacterium and 
Staphylococcus species with slightly sensitive strains. This is 
more likely to lead to therapeutic failure due to initial inadequate 
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concentration of antibiotic to totally eradicate the 
microorganism. It could also result to the presence of resistant 
strains of the organism due to exposure to suboptimal dose since 
previous studies have shown that the lung is the region where 
Mycobacterium organism inhabits (Kjellsson et al., 2012). 
 Ascertaining the concentration of administered drug in 
different cavities like the lungs is of paramount importance 
because some macrophages and neutrophils needed for the 
sustenance of M. tuberculosis are found growing in such region; 
hence maximum concentration is inevitable (Kaplan, 2003; 
Eum, 2010). Furthermore, poor prognosis and development 
resistance to tuberculosis treatment is associated with the 
presence and extent of organism growing in these cavities 
(Chang et al., 2004; Kim, 2008). Hence, any agent that affects 
the penetration of anti-TB agents into the lung is of great 
importance as it affects therapeutic goals. 
 Data analysis showed that there was no significant difference 
(P = 0.10) in the effect obtained from 100 mg/kg Garcinia kola 
compared to that of 200 mg/kg, hence the G. kola did not show 
a dose dependent effect.  
 In conclusion, our results reveal that Garcinia kola impairs 
the pharmacokinetic profile of rifampicin when administered 
concurrently. It reduced the Cmax, AUC, t1/2 and clearance of 
rifampicin resulting in decreased bioavailability. It also 
significantly reduced the concentration of rifampicin in lungs 
tissue.  Hence, patients and health practitioners are advised 
against concurrent consumption of rifampicin and G. kola. If 
both of them should be taken, a time interval should be observed 
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